Building companies · Following capital · Studying opportunity

Where African opportunity is forming, before it becomes obvious.

A publication of observations, perspectives and conversations exploring where opportunity is forming, and how ideas become reality in complex environments.

The objective is simple: identify opportunities early, understand them deeply, and document them before they become obvious.

Across healthcare, life sciences, regulation, capital and emerging opportunities in African markets.

The Opportunity Radar

The signal, before it is obvious

A live ledger of where African opportunity is forming before the consensus does. Closer to a private investment memo than a news feed, and unlike news it compounds. The earliest entries tend to be the most valuable.

01High · Active

Rare Disease Market Access

Healthcare
The access routes are opening faster than anyone is moving to use them.
02High · Emerging

Medicines Regulatory Harmonisation

Regulation
A single market for medicines is being built in the background, while everyone watches the foreground.
03High · Developing

Decentralised Clinical Trials

Clinical Research
Cheaper trials and better data lead to the same place, sponsors will follow.
04Medium · Active

Specialty Pharma Access

Healthcare
Own the cold chain and you own specialty access.
05Medium · Developing

AI-Assisted Diagnostics

Technology
The bottleneck is reimbursement and workflow, not the model.
06Medium · Maturing

Frontier Credit Dislocation

Capital
The market priced a continent; the opportunity is in the exceptions.
See the full radar →

Signals

Between the news and the essays

Not a news feed. Short reads on what is developing, why it matters, and which Radar thesis it touches.

June 2026Medicines Regulatory Harmonisation

The African Medicines Agency keeps quietly assembling.

Each appointment and ratification moves a single continental medicines market from treaty language toward something operational, the precondition for collapsing approval timelines.

June 2026Device & IVD Regulation

Device and IVD regulation is starting to formalise.

As SAHPRA and regional bodies draft device and diagnostic rules, the window to understand them before they harden is open now, not later.

June 2026Frontier Credit Dislocation

Frontier African credit is being repriced name by name.

The block selloff is giving way to differentiation. Quality issuers punished for their neighbours are where the mispricing now sits.

All signals →

Latest writing

Notebook & Conversations
Healthcare

Why African rare disease is a market, not a mission

Unmet need is not charity; the quiet build-out of access pathways across Africa describes a commercial opportunity wearing a moral disguise.

June 2026 · 4 min
Capital

The quiet repricing of frontier credit

Default makes headlines; mispricing makes returns. Which African issuers were punished for their neighbours' problems rather than their own?

May 2026 · 4 min
Conversation

On the economics of decentralised trials

A clinical-operations lead, running multi-country studies, on what actually makes a trial cheaper, and what only looks like it does.

May 2026 · 1 min
Regulation

Section 21 and the architecture of access

South Africa's named-patient route looks like a loophole; read closely it is a working blueprint for how unregistered medicines reach patients.

May 2026 · 4 min
Conversation

What regulators actually want

A former medicines-agency reviewer on timelines, evidence, and the gap between what sponsors submit and what regulators need.

April 2026 · 1 min

Most read

Where new readers begin

What I'm watching

Personal · updated monthly

Looser than the Radar, and more personal. The open questions I am sitting with this month.

Notes No. 01

The flagship object
Notes
2027
No. ____ of 1000
43 preordered · 957 remaining

A blank, individually numbered notebook. Made in South Africa. One thousand copies, produced once, never reprinted. An object to carry and fill, not to read.

Made in South Africa1,000 numberedProduced once a year

The flagship object of the Collection. Blank; you complete it.

See Notes No. 01 →
VenturesWhere ideas become reality

Keep a notebook open with me.

Essays, interviews and the Opportunity Radar. Sent only when something is worth your attention.

Prefer RSS? Subscribe by feed →